Press monitoring

Medtronic Launches Percutaneous Tibial Neuromodulation Delivered by the NURO System for the Treatment of Overactive Bladder (OAB)

30.3.2016   |   Press monitoring

New Medtronic Treatment Targets Underlying Bladder and Brain Miscommunication and Could Bring Desperately Needed Relief to Tens of Millions Struggling with OAB. DUBLIN - March 30, 2016 - Medtronic plc (NYSE: MDT) today announced the launch of its NURO(TM) System that delivers percutaneous tibial neuromodulation (PTNM) for the treatment of...

Continue


Wounds may be treated using ... frog foam?

30.3.2016   |   Press monitoring

When the tiny Tungara frog lays its eggs, it also secretes a protein cocktail that it beats into a foam using its back legs. Surrounding the eggs, that foam protects them from predators, germs and environmental stress. As it turns out, a synthetic version of the substance may also one day have another use – delivering medication to serious skin...

Continue


Herantis Pharma receives orphan designation of CDNF for treatment of ALS

29.3.2016   |   Press monitoring

The European Medicines Agency's Committee for Orphan Medicinal Products (COMP) has issued a positive opinion on the application of Herantis Pharma Plc ("Herantis") for orphan drug designation of recombinant human Cerebral Dopamine Neurotrophic Factor (CDNF) for treatment of amyotrophic lateral sclerosis (ALS).

Continue


Modified maggots could help human wound healing

28.3.2016   |   Press monitoring

In a proof-of-concept study, NC State University researchers show that genetically engineered green bottle fly (Lucilia sericata) larvae can produce and secrete a human growth factor -- a molecule that helps promote cell growth and wound healing. Sterile, lab-raised green bottle fly larvae are used for maggot debridement therapy (MDT), in which...

Continue


IBA Signs Contract with UZ Leuven to Install the First Proton Therapy Center in Belgium

25.3.2016   |   Press monitoring

Louvain-la-Neuve, Belgium, March 25, 2016 - IBA (Ion Beam Applications SA), the world's leading provider of proton therapy solutions for the treatment of cancer, announces today that it has signed a contract with the University Hospitals Leuven (UZ Leuven) and Katholieke Universiteit Leuven (KU Leuven) to install Belgium's first proton therapy...

Continue


DNA molecules directly interact with each other based on sequence

25.3.2016   |   Press monitoring

Proteins play a large role in DNA regulation, but a new study finds that DNA molecules directly interact with one another in a way that's dependent on the sequence of the DNA and epigenetic factors. This could have implications for how DNA is organized in the cell and even how genes are regulated in different cell types, the researchers...

Continue


Bio-on and Italeri unite to use Minerv PHA Supertoys in the toys and models of the future

24.3.2016   |   Press monitoring

BOLOGNA, 24 March 2016 - Bio-on announces the launch of a new collaboration with Italeri S.p.A. , a production and distribution leader in the modelling sector. Thanks to this agreement, the manufacture of scale models will be done for the first time with the special grade Minerv PHA Supertoys, the new type of bioplastic developed by Bio-on...

Continue


Active Biotech plans to develop tasquinimod for the treatment of multiple myeloma

23.3.2016   |   Press monitoring

Lund, March 23, 2016 - Active Biotech (Nasdaq Stockholm: ACTI) today announces that a patent application for the treatment of multiple myeloma with the company's compound tasquinimod, together with an international search report, will be public within short on WIPO's (World Intellectual Property Organization) web site www.wipo.int . With this...

Continue


Gene editing could provide a cure for HIV

23.3.2016   |   Press monitoring

While antiretroviral drugs do a good job of keeping HIV infections under control, scientists are working hard to come up with a full cure for the condition. A team of researchers from the Lewis Katz School of Medicine at Temple University is making real progress in that regard, successfully testing a gene editing system, demonstrating its ability...

Continue


Navamedic enters into agreement with Pennine Healthcare as distributor for Sippi® in the UK

22.3.2016   |   Press monitoring

Navamedic ASA (OSE: NAVA), the Norwegian Medtech and pharmaceutical products company, announced today that an agreement has been signed with UK-based Pennine Healthcare, a leading distributor and manufacturer of sterile medical devices, for the launch of Sippi® in Great Britain, Ireland and Northern Ireland.

Continue


 

OPPI, MPO, EU

CEBIO

  • ALIDEA
  • CEBIO
  • BC AV CR
  • Budvar
  • CAVD
  • CZBA
  • Eco Tend
  • Envisan Gem
  • Gentrend
  • JAIP
  • Jihočeská univerzita
  • Madeta
  • Forestina

LinkedIn
TOPlist